Your browser doesn't support javascript.
loading
A Double-Blind Randomized Placebo-Controlled Trial of Citalopram Adjunctive to Stimulant Medication in Youth With Chronic Severe Irritability.
Towbin, Kenneth; Vidal-Ribas, Pablo; Brotman, Melissa A; Pickles, Andrew; Miller, Katherine V; Kaiser, Ariela; Vitale, Aria D; Engel, Chana; Overman, Gerald P; Davis, Mollie; Lee, Beth; McNeil, Cheri; Wheeler, Wanda; Yokum, Catherine H; Haring, Catherine T; Roule, Alexandra; Wambach, Caroline G; Sharif-Askary, Banafsheh; Pine, Daniel S; Leibenluft, Ellen; Stringaris, Argyris.
Afiliação
  • Towbin K; Mood Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Vidal-Ribas P; Mood Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD; Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
  • Brotman MA; Neuroscience and Novel Therapeutics, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Pickles A; Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
  • Miller KV; Mood Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Kaiser A; Mood Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Vitale AD; Mood Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Engel C; Mood Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Overman GP; National Institutes of Health, Bethesda, MD.
  • Davis M; Section on Mood Dysregulation and Neuroscience, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Lee B; College of Nursing, University of Arizona, Tuscon.
  • McNeil C; Section on Mood Dysregulation and Neuroscience, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Wheeler W; Section on Mood Dysregulation and Neuroscience, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Yokum CH; Section on Mood Dysregulation and Neuroscience, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Haring CT; University of Michigan, Ann Arbor.
  • Roule A; Penn State University, State College, PA.
  • Wambach CG; Georgetown University School of Medicine, Washington, DC.
  • Sharif-Askary B; Duke University School of Medicine, Durham, NC.
  • Pine DS; Section on Development and Affective Neuroscience, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Leibenluft E; Section on Mood Dysregulation and Neuroscience, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
  • Stringaris A; Mood Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD. Electronic address: argyris.stringaris@nih.gov.
J Am Acad Child Adolesc Psychiatry ; 59(3): 350-361, 2020 03.
Article em En | MEDLINE | ID: mdl-31128268

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estimulantes do Sistema Nervoso Central / Metilfenidato Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estimulantes do Sistema Nervoso Central / Metilfenidato Idioma: En Ano de publicação: 2020 Tipo de documento: Article